<Disease><Name>LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2</Name><Synonym>BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 2</Synonym><OMIM><Number>269700</Number><URL>http://omim.org/entry/269700</URL></OMIM><Orphanet><Number>528</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=528</URL></Orphanet><Protein><Number>Seipin</Number><URL>http://www.uniprot.org/uniprot/Q96G97</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>11q12.3</Gene><ICD>E88.1</ICD><Summary>rare;autosomal recessive;mutations in the seipin gene (BSCL2)</Summary><Symptoms><symtomp><id>3852</id><symptom>acanthosis nigrans</symptom><category>SKIN</category></symtomp><symtomp><id>3333</id><symptom>bone age, advanced</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3062</id><symptom>diabetes mellitus</symptom><category>GASTROINTESTINAL SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3371</id><symptom>hirsutism</symptom><category>ENDOCRINE SYSTEM</category></symtomp><symtomp><id>1881</id><symptom>increased growth velocity</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2210</id><symptom>pancreatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3236</id><symptom>polycystic ovaries</symptom><category>ENDOCRINE SYSTEM | GENITOURINARY TRACT</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1909</id><symptom>umbilical hernia</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2236</id><symptom>urolithiasis, nephrolithiasis, kidney stones</symptom><category>GENITOURINARY TRACT</category></symtomp></Symptoms><Metabolites><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>294</id><name>Triglycerides</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>128.00</max><unit>mg/dl</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>491</id><name>Triglycerides</name><specimen>serum</specimen><value>increased</value><min>30.00</min><max>99.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1008</id><name>Triglycerides</name><specimen>various tissues</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>5334</id><title>Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy</title><author>Chen R,</author><journal>Gene</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5335</id><title>High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli-Seip syndrome</title><author>Purizaca-Rosillo N,</author><journal>Am J Med Genet A</journal><year>2017</year><book /><volume>173</volume><number>2</number><pages>471-478</pages><co_aut>et al.</co_aut></literature><literature><id>5336</id><title>Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy type 2: Report of 3 cases and literature review</title><author>Opri R,</author><journal>Seizure</journal><year>2016</year><book /><volume>42</volume><number>0</number><pages>1-6</pages><co_aut>et al.</co_aut></literature><literature><id>5337</id><title>Towards a mechanistic understanding of lipodystrophy and seipin functions</title><author>Wee K,</author><journal>Biosci Rep</journal><year>2014</year><book /><volume>34</volume><number>5</number><pages>e00141</pages><co_aut>et al.</co_aut></literature><literature><id>5338</id><title>Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy</title><author>Van Maldergem L,</author><journal>J Med Genet</journal><year>2002</year><book /><volume>39</volume><number>10</number><pages>722-733</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>